Sanjiv B Amin1, Theresa Harte, Lori Scholer, Hongyue Wang. 1. Division of Neonatology, Department of Pediatrics, University of Rochester School of Medicine, Rochester, New York 14642, USA. sanjiv_amin@urmc.rochester.edu
Abstract
BACKGROUND: The lipid intake at which a significant bilirubin-displacing effect occurs as a function of gestational age (GA) is unclear. OBJECTIVE: To determine the effect of gradual increase in IL intake from 1.5 to 3 g/kg per day on bilirubin-albumin binding variables as a function of GA in premature infants with indirect hyperbilirubinemia. METHODS: Infants of 24 to 33 weeks' gestation at birth who received IL (20% Intralipid [Fresenius Kabi, Uppsala, Sweden]) doses of 1.5, 2, 2.5, and 3 g/kg per day over 4 consecutive days were prospectively evaluated. The blood samples were drawn twice at least 8 hours apart on each IL intake to measure total serum bilirubin and free bilirubin by the peroxidase test. The highest free bilirubin on each IL intake, the corresponding total serum bilirubin, and serum albumin were used to calculate the bilirubin/albumin binding constant or binding affinity. RESULTS: Sixty-two infants (median GA: 28 weeks) were studied during the first 10 days of life. None of the subjects had culture-proven sepsis, had triglyceride levels of >2.05 mmol/L, or were receiving steroids. Infants were grouped in 2-week GA intervals. The cumulative frequency of elevated free bilirubin concentration (>or=90th percentile or B(f) >or= 32 nmol/L) as a function of IL intake was inversely related to GA and was significantly different among 2-week GA groups. There was significant decrease in binding affinity and increase in free bilirubin concentration with higher IL intake for <or=28 week but not for >28 week GA groups. CONCLUSIONS: The IL intake may be associated with a significant fall in the binding affinity of bilirubin for plasma protein and a concomitant increase in free bilirubin concentration in premature infants. The lipid intake at which this occurs depends on GA.
BACKGROUND: The lipid intake at which a significant bilirubin-displacing effect occurs as a function of gestational age (GA) is unclear. OBJECTIVE: To determine the effect of gradual increase in IL intake from 1.5 to 3 g/kg per day on bilirubin-albumin binding variables as a function of GA in premature infants with indirect hyperbilirubinemia. METHODS:Infants of 24 to 33 weeks' gestation at birth who received IL (20% Intralipid [Fresenius Kabi, Uppsala, Sweden]) doses of 1.5, 2, 2.5, and 3 g/kg per day over 4 consecutive days were prospectively evaluated. The blood samples were drawn twice at least 8 hours apart on each IL intake to measure total serum bilirubin and freebilirubin by the peroxidase test. The highest freebilirubin on each IL intake, the corresponding total serum bilirubin, and serum albumin were used to calculate the bilirubin/albumin binding constant or binding affinity. RESULTS: Sixty-two infants (median GA: 28 weeks) were studied during the first 10 days of life. None of the subjects had culture-proven sepsis, had triglyceride levels of >2.05 mmol/L, or were receiving steroids. Infants were grouped in 2-week GA intervals. The cumulative frequency of elevated freebilirubin concentration (>or=90th percentile or B(f) >or= 32 nmol/L) as a function of IL intake was inversely related to GA and was significantly different among 2-week GA groups. There was significant decrease in binding affinity and increase in freebilirubin concentration with higher IL intake for <or=28 week but not for >28 week GA groups. CONCLUSIONS: The IL intake may be associated with a significant fall in the binding affinity of bilirubin for plasma protein and a concomitant increase in freebilirubin concentration in premature infants. The lipid intake at which this occurs depends on GA.
Authors: Richard P Wennberg; Charles E Ahlfors; Vinod K Bhutani; Lois H Johnson; Steven M Shapiro Journal: Pediatrics Date: 2006-02 Impact factor: 7.124
Authors: Charles E Ahlfors; Hendrik J Vreman; Ronald J Wong; G Jesse Bender; William Oh; Brenda H Morris; David K Stevenson Journal: Clin Biochem Date: 2006-09-29 Impact factor: 3.281
Authors: M L Spear; G E Stahl; M H Paul; J M Egler; G R Pereira; R A Polin Journal: JPEN J Parenter Enteral Nutr Date: 1985 Mar-Apr Impact factor: 4.016
Authors: Thomas Hegyi; Alan Kleinfeld; Andrew Huber; Barry Weinberger; Naureen Memon; Weichung Joe Shih; Mary Carayannopoulos; William Oh Journal: J Pediatr Date: 2017-01-17 Impact factor: 4.406
Authors: Thomas Hegyi; Alan Kleinfeld; Andrew Huber; Barry Weinberger; Naureen Memon; Weichung Shih; Mary Carayannopoulos; William Oh Journal: J Matern Fetal Neonatal Med Date: 2018-03-12